These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 28625240)

  • 1. [Dynamic changes of complement level in patients with acute coronary syndrome and its relationships with myocardial injury].
    Shao A; Qi X; Li Q; Jia W; Wei L; Hou W; Qi Y; Liu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):515-519. PubMed ID: 28625240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
    Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T
    Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
    Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
    ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.
    Batra G; Renlund H; Kunadian V; James SK; Storey RF; Steg PG; Katus HA; Harrington RA; Gibson CM; Budaj A; Siegbahn A; Wallentin L
    Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(4):336-349. PubMed ID: 35213721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin in ST segment elevation and non-ST segment elevation acute coronary syndromes: a novel finding.
    Cosansu K; Cakmak HA; Ikitimur B; Yildirim E; Can G; Karadag B; Koldas L
    Kardiol Pol; 2014; 72(3):239-45. PubMed ID: 24142748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trend of clinical features in patients with acute coronary syndrome undergoing emergent percutaneous coronary intervention].
    Zhou JY; Liu C; Zhou P; Tan Y; Li JN; Sheng ZX; Zhao HJ; Song L; Yang YM; Wu Y; Yan HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Oct; 46(10):790-794. PubMed ID: 30369169
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
    Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events.
    Dogan A; Icli A; Aksoy F; Varol E; Erdogan D; Ozaydin M; Kocyigit S
    Coron Artery Dis; 2012 Jan; 23(1):39-44. PubMed ID: 22107801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].
    Wang YY; Li T; Liu YW; Liu BJ; Hu XM; Wang Y; Gao WQ; Wu P; Huang L; Li X; Peng WJ; Ning M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):277-282. PubMed ID: 28545277
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnostic role of signal peptide-C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein 1 in non-ST-elevation acute coronary syndrome.
    Sonmez E; Turkdogan KA; Karabacak M; Civelek C; Yilmaz C; Ozer OF; Çavuş UY
    Am J Emerg Med; 2015 Jan; 33(1):21-4. PubMed ID: 25445868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
    Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
    Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
    Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
    J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.